Merck Lipfendra Approval: FDA Clears Breakthrough Pill as Stock Drops -1.75%
Will the revolutionary Merck Lipfendra Approval be enough to offset the looming $32 billion Keytruda patent cliff for investors?
Intel Price Target Lifted to $115 as Stock Plunges 5.5%
Can Christopher Rolland's massive price target upgrade save Intel from the brutal tech sell-off dragging shares under $100?
Joby Aviation Insider Sale: Stock Drops -4.9% After SEC Filing
Is the latest Joby Aviation insider sale a warning sign for investors, or is the market overreacting to a routine tax event?
Prologis Acquisition Speculation and Q2 Beat Send Stock Up 3.8%
Could a massive European takeover solidify this logistics giant's global dominance, or is the market overreacting to the rumors?
BlackBerry Earnings: Stock Drops -9.2% Despite Strong Q1 Beat
Can BlackBerry's ambitious Nvidia partnership for physical AI reverse the sudden stock plunge despite beating quarterly expectations?
Abbott Laboratories Earnings: Stock Surges 11% on Q2 Beat
Can Abbott Laboratories' upgraded full-year outlook sustain this massive double-digit stock rally, or is the relief surge short-lived?
Lucid Bankruptcy Rumors Denied: Stock Surges +14.7% on CEO Comments
Will the CEO's aggressive denial of recent insolvency reports be enough to permanently silence the bears and save the luxury EV maker?
Broadcom Partnership Drops -3.5% Despite Massive Apple Deal
Can Broadcom's massive new multi-billion dollar partnerships shield the chipmaker from the latest market sell-off?
Enphase EV Charger Launches in Europe as Stock Slides -2%
Can the newly launched Enphase EV Charger revive European sales and reverse the stock's recent downward trend?
Coinbase Stock Drops 2.25% as Crypto Volatility Shakes Market
Can Coinbase successfully decouple its stock price from daily crypto volatility by expanding its institutional custody services?